CIRCLE WITH A DOT

Dr. Rogan cofounded Cytognomix Inc. in London, Ontario in 2008. The company commercializes genomic and cytogenetic reagents and software based on technologies developed over the past 30 years. Current products automate radiation biodosimetry, interpret variation in genomic sequences, and predict response to chemotherapies based on genomic signatures.
He is also Professor Emeritus of Biochemistry and Oncology at Western University.